[go: up one dir, main page]

RU94046312A - Use of biologically active ureido-derivatives for treatment lentivirus-induced disease, products containing ureido-derivatives - Google Patents

Use of biologically active ureido-derivatives for treatment lentivirus-induced disease, products containing ureido-derivatives

Info

Publication number
RU94046312A
RU94046312A RU94046312/14A RU94046312A RU94046312A RU 94046312 A RU94046312 A RU 94046312A RU 94046312/14 A RU94046312/14 A RU 94046312/14A RU 94046312 A RU94046312 A RU 94046312A RU 94046312 A RU94046312 A RU 94046312A
Authority
RU
Russia
Prior art keywords
derivatives
ureido
treatment
lentivirus
biologically active
Prior art date
Application number
RU94046312/14A
Other languages
Russian (ru)
Other versions
RU2142798C1 (en
Inventor
Монджелли Никола
It]
Биасоли Джованни
Гранди Мария
Чиомеи Марина
Кристина Джерони Мария
Original Assignee
Фармиталиа Карло Эрба С.р.л. (IT)
Фармиталиа Карло Эрба С.Р.Л.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фармиталиа Карло Эрба С.р.л. (IT), Фармиталиа Карло Эрба С.Р.Л. filed Critical Фармиталиа Карло Эрба С.р.л. (IT)
Publication of RU94046312A publication Critical patent/RU94046312A/en
Application granted granted Critical
Publication of RU2142798C1 publication Critical patent/RU2142798C1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

FIELD: organic chemistry. SUBSTANCE: product: compound of the formula (I)where each m and n that are similar = 1-3; each of R-groups that are similar is naphthyl substituted with 1-3 sulfo-groups, or its pharmaceutically acceptable salt. Synthesized compound were used for treatment of infections caused by lentiviruses. EFFECT: improved method of synthesis, enhanced effectiveness of treatment.

Claims (1)

Для приготовления лекарственного средства, предназначенного для лечения инфекции лентивируса, предложено соединение формулы, приведенной в описании, или его фармацевтически приемлемая соль.For the preparation of a medicinal product intended for the treatment of lentivirus infection, a compound of the formula described in the description or a pharmaceutically acceptable salt thereof is provided.
RU94046312A 1993-04-16 1994-03-29 Agent based on biologically active ureido-derivatives for treatment of patients with infections caused by lentivirus RU2142798C1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939307948A GB9307948D0 (en) 1993-04-16 1993-04-16 Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease
GB9307948.1 1993-04-16
PCT/EP1994/000984 WO1994023718A1 (en) 1993-04-16 1994-03-29 Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease

Publications (2)

Publication Number Publication Date
RU94046312A true RU94046312A (en) 1996-10-20
RU2142798C1 RU2142798C1 (en) 1999-12-20

Family

ID=10733998

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94046312A RU2142798C1 (en) 1993-04-16 1994-03-29 Agent based on biologically active ureido-derivatives for treatment of patients with infections caused by lentivirus

Country Status (15)

Country Link
EP (1) EP0646004A1 (en)
JP (1) JPH07508044A (en)
KR (1) KR950701812A (en)
AU (1) AU670194B2 (en)
CA (1) CA2137148A1 (en)
CZ (1) CZ282988B6 (en)
GB (1) GB9307948D0 (en)
HU (1) HU216834B (en)
IL (1) IL109235A (en)
NO (1) NO307126B1 (en)
PL (1) PL306798A1 (en)
RU (1) RU2142798C1 (en)
TW (1) TW308593B (en)
UA (1) UA42693C2 (en)
WO (1) WO1994023718A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9504065D0 (en) * 1995-03-01 1995-04-19 Pharmacia Spa Poly-pyrrolecarboxamidonaphthalenic acid derivatives
GB9602721D0 (en) * 1996-02-09 1996-04-10 Pharmacia Spa Biologically active ureido derivatives useful in the treatment of multiple sclerosis
GB2310207A (en) * 1996-02-15 1997-08-20 Pharmacia Spa Antiviral ureido derivatives of substituted heterocyclic compounds
GB9713733D0 (en) * 1997-06-27 1997-09-03 Pharmacia & Upjohn Spa Poly-branched polycarboxamido compounds
EP3381897A1 (en) 2017-03-27 2018-10-03 Leadiant Biosciences SA Derivatives of the disodium 2,2'-{carbonylbis[imino-3,1-phenylenecarbonylimino(1-methyl-1h-pyrrole-4,2-diyl)carbonylimino]}dinaphthalene-1,5-disulfonate salt and related compounds as heparanase inhibitors for the treatment of cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9000644D0 (en) * 1990-01-11 1990-03-14 Erba Carlo Spa New ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds
WO1992013838A1 (en) * 1991-02-06 1992-08-20 Synphar Laboratories, Inc. Oligopeptide antiretroviral agents
IT1247878B (en) * 1991-02-15 1995-01-05 Menarini Farma Ind POLY-4-AMINOPYRROL-2-CARBOXYXID DERIVATIVES, PREPARATION PROCESSES AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM

Also Published As

Publication number Publication date
JPH07508044A (en) 1995-09-07
UA42693C2 (en) 2001-11-15
WO1994023718A1 (en) 1994-10-27
AU6537194A (en) 1994-11-08
CZ282988B6 (en) 1997-12-17
RU2142798C1 (en) 1999-12-20
HU9500120D0 (en) 1995-03-28
IL109235A (en) 1998-09-24
AU670194B2 (en) 1996-07-04
PL306798A1 (en) 1995-04-18
NO944809D0 (en) 1994-12-12
NO307126B1 (en) 2000-02-14
EP0646004A1 (en) 1995-04-05
GB9307948D0 (en) 1993-06-02
IL109235A0 (en) 1994-07-31
TW308593B (en) 1997-06-21
CZ10795A3 (en) 1995-09-13
CA2137148A1 (en) 1994-10-27
HUT71838A (en) 1996-02-28
KR950701812A (en) 1995-05-17
NO944809L (en) 1994-12-12
HU216834B (en) 1999-09-28

Similar Documents

Publication Publication Date Title
RU94036758A (en) Use of 2-phenyl-3-aroylbenzothiophenes for peri-menopause syndrome
RU95106362A (en) Lipopeptide derivatives, process for preparation thereof, pharmaceutical composition containing said derivatives, and process for preparation of said composition
RU94022258A (en) New sulfonylaminopyrimidines
GEP20002298B (en) Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment
RU94046294A (en) Steroid glycosides for hypercholesterolemia treatment
RU94041223A (en) Agent for motoneuron disease treatment
RU94027569A (en) ORGANIC SALTS N, N'-DIACETHILTSISTINA, METHOD OF PRODUCTION, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT
RU94022743A (en) Amido and carbamido derivatives having antihypercholesteric activity, preparation thereof, and therapeutic use thereof
RU94041950A (en) Use of compounds of 3-arylhydroxypropylamine order for enuresis treatment
ATE83659T1 (en) USE OF INDOLON DERIVATIVES FOR THE MANUFACTURE OF PHARMACEUTICALS FOR THE TREATMENT OF PARKINSONISM.
RU94028670A (en) Immunopotentiating agents, methods of treatment of immunodeficient mammalian, viral infections and cancer in mammalian also
RU94044436A (en) Method of suppression of skin and vagina atrophy
NO890259D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ETHYLPHENOXYACETAMIDES.
DE69019533D1 (en) TREATMENT OF HIV INFECTIONS AND USEFUL LINKS THEREFOR.
RU94046093A (en) 7-(2-aminoethyl)benzothiazolone derivatives, process for preparation thereof, intermediate compounds, and pharmcomposition
RU94046141A (en) Substituted(arylalkoxybenzyl)aminopropaneamide derivatives, processes for preparation thereof, and pharmaceutical composition
ES2128043T3 (en) USE OF BIS (AMIDINOBENCIMIDAZOLES) IN THE PREPARATION OF A MEDICINAL PRODUCT TO INHIBIT RETROVIRAL INTEGRASE.
DK0736029T3 (en) Anticonvulsant pseudofructopyranose sulfamates
RU94045271A (en) Use of 2-phenyl-3-aroylbenzothiophenes for terner's syndrome inhibition
UA48958C2 (en) 9-0-oxime derivatives of erythromycine and pharmaceutical composition thereof
RU94039545A (en) New adenosine derivatives, methods of their synthesis, pharmaceutical compositions based on thereof, methods of preparing pharmaceutical compositions and their use
BG60101B2 (en) METHOD FOR THE PREPARATION OF 4-FLUORO-2-(((4-METHOXY-2- PYRIDINYL)METHYL)THIONYL)-1H-BENZIMIDAZOLE
GEP19991872B (en) Novel Taxoids, Preparations Thereof, and Pharmaceutical Compositions Containing Same
RU95110110A (en) Derivatives of benzofuran, method of their synthesis, pharmcomposition, treatment method
RU94046312A (en) Use of biologically active ureido-derivatives for treatment lentivirus-induced disease, products containing ureido-derivatives